Trials to treatments: targeting alpha-syn... - Cure Parkinson's
Trials to treatments: targeting alpha-synuclein
Written by
Farooqji
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Do animal proteins cause an increase in alpha synuclein?
of prion-like α-synuclein
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701169/...
Effect of Dietary Ketosis On Alpha-Synuclein Accumulation
cells in Parkinson's....
Parkinson's Disease: emerging treatment target, the NLRP inflammasome.
cycle of neuroinflammation and α-synuclein buildup in the brain....
Cough syrup drug being trialed as Parkinson’s treatment
https://neurosciencenews.com/parkinsons-ambroxol-15712/
Ambroxol, a medication approved to treat...
Safety and Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS Trial
Efficacy of TUDCA as add-on Treatment in Patients Affected by ALS Trial...
Related Posts
ALA: Alpha-Lipoic Acid
Aspirin targets key protein in neurodegenerative diseases - updates? 
Understanding how misfolded alpha syneclein spreads in the brain and how to stop it's spread- Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy? 2021
Stemregen in clinical trial
